These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Use of a new protocol for prolactin extraction and reduction of false hyperprolactinemia]. Robles Rodríguez JL; Castaño López MA Endocrinol Nutr; 2010; 57(7):296-300. PubMed ID: 20542746 [TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of serum prolactin analysis in pituitary function tests]. Aono T Nihon Rinsho; 1989 Dec; 48 Suppl():1085-8. PubMed ID: 2621824 [No Abstract] [Full Text] [Related]
25. Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect. Dagdelen S; Usman A Minerva Endocrinol; 2010 Jun; 35(2):53-9. PubMed ID: 20595935 [TBL] [Abstract][Full Text] [Related]
26. Olanzapine-Induced Hyperprolactinemia: Two Case Reports. Barata PC; Santos MJ; Melo JC; Maia T Front Pharmacol; 2019; 10():846. PubMed ID: 31417404 [No Abstract] [Full Text] [Related]
27. [Prolactin and the laboratory]. Veloza A; Prazeres S Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514 [TBL] [Abstract][Full Text] [Related]
28. Changes in circadian rhythm of prolactin in short children are dependent on growth hormone secretion. Stawerska R; Smyczyńska J; Hilczer M; Lewiński A Ann Agric Environ Med; 2014; 21(2):445-9. PubMed ID: 24959807 [TBL] [Abstract][Full Text] [Related]
29. [Macroprolactinemia, a benign form of hyperprolactinemia]. Vos MC; Land JA; Menheere PP; Evers JL Ned Tijdschr Geneeskd; 2001 May; 145(20):967-70. PubMed ID: 11396264 [TBL] [Abstract][Full Text] [Related]
30. Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association. Herranz M; Pombo M; Menendez-Rodriguez P; Arias JI; Ruibal A Gynecol Endocrinol; 2012 Apr; 28(4):278-81. PubMed ID: 22420628 [TBL] [Abstract][Full Text] [Related]
31. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Kopecek M; Bares M; Horacek J; Mohr P Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006 [TBL] [Abstract][Full Text] [Related]
32. [Hyperprolactinemia in malignant lymphomas]. Grobe N; Rühle H; Eckelmann G Dtsch Med Wochenschr; 1990 Nov; 115(48):1825-7. PubMed ID: 2245764 [TBL] [Abstract][Full Text] [Related]
33. Hyperprolactinemia in children during the peripubertal period--personal observations. Noczyńska A; Wasikowa R J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1399-404. PubMed ID: 15526718 [TBL] [Abstract][Full Text] [Related]
34. Hyperprolactinemia after low dose of amisulpride. Kopecek M; Bares M; Svarc J; Dockery C; Horácek J Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803 [TBL] [Abstract][Full Text] [Related]
35. Quantitative adjustment for macroprolactin is an integral part of laboratory assessment of hyperprolactinaemia. Heald AH; Blantern E; Anderson SG; Radford D; Qureshi Z; Nair S; Waldron J; Davies M; McCulloch A; Kane J Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):376-80. PubMed ID: 22576261 [TBL] [Abstract][Full Text] [Related]
36. Macroprolactin, big-prolactin and potential effects on the misdiagnosis of hyperprolactinemia using the Beckman Coulter Access Prolactin assay. Ellis MJ; Livesey JH; Soule SG Clin Biochem; 2006 Oct; 39(10):1028-34. PubMed ID: 16919253 [TBL] [Abstract][Full Text] [Related]
37. An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? Di Sarno A; Rota F; Auriemma R; De Martino MC; Lombardi G; Colao A J Endocrinol Invest; 2003; 26(7 Suppl):39-47. PubMed ID: 14604065 [TBL] [Abstract][Full Text] [Related]
38. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405 [TBL] [Abstract][Full Text] [Related]
39. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report]. Owecki M; Sowiński J Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710 [TBL] [Abstract][Full Text] [Related]